MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $129,000 | -56.0% | 10,396 | -52.7% | 0.02% | -22.2% |
| Q1 2022 | $293,000 | -89.7% | 21,976 | -82.7% | 0.03% | -83.0% |
| Q3 2021 | $2,848,000 | -25.6% | 126,915 | -24.5% | 0.16% | -23.9% |
| Q2 2021 | $3,827,000 | +1696.7% | 168,090 | +1529.3% | 0.21% | +497.1% |
| Q2 2020 | $213,000 | – | 10,317 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |